Climate change and cancer: the Environmental Justice perspective
Abstract. Despite advances in cancer control—prevention, screening, diagnosis, treatment, and survivorship—racial disparities in cancer incidence and survi
Abstract. Despite advances in cancer control—prevention, screening, diagnosis, treatment, and survivorship—racial disparities in cancer incidence and survi
She will oversee the Moffitt Medical Group
Here, we summarize a randomized trial comparing disease control and immediate hematopoietic stem cell transplant vs standard salvage chemotherapy to induce remission prior to transplant…
This study examines 2 randomized clinical trials to assess the efficacy and safety of the oral gonadotropin-releasing hormone antagonist relugolix with radiotherapy for treating prostate…
Zanidatamab therapy led to confirmed responses, disease control, and favorable overall survival in pretreated HER2+ biliary tract cancer in an update of the HERIZON-BTC-01 trial.
Stephen V. Liu, MD, details the phase 1/2 ARROS-1 study evaluating the selective ROS1 inhibitor zidesamtinib in patients with ROS1 fusion–positive non–small cell lung cancer.
Heart Failure Deadline to submit: 30 June 2024 During the 2023 focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute…
Virtual webinar hosted by VJHemOnc featuring presentations & discussions on selected abstracts in lymphoma from ASCO & EHA 2024. Chaired by Dr Anna Sureda 28…
The FDA’s Medical Devices Advisory Committee recommends the approval of the Shield blood test for CRC screening in adults at average risk for CRC.
Nature Reviews Clinical Oncology – Following the introduction of blinatumomab in 2014, the past 4 years have seen the approval of a further ten bispecific…
An official journal of the European Society of Cardiology. Publishes high quality material, both clinical and scientific, on all aspects of Cardiovascular Medicine – including…